Published in J Cancer Educ on June 01, 2012
Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract (2014) 0.76
Community-based initiatives improving critical health literacy: a systematic review and meta-synthesis of qualitative evidence. BMC Public Health (2017) 0.75
Qualitative research in health care. Using qualitative methods in health related action research. BMJ (2000) 2.84
Genetic testing: psychological aspects and implications. J Consult Clin Psychol (2002) 1.93
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns (2004) 1.69
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg (2003) 1.57
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer (2006) 1.30
Addressing the issue of e-learning and online genetics for health professionals. Nurs Health Sci (2007) 1.15
How can action research apply to health services? Qual Health Res (2001) 1.05
Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. J Natl Compr Canc Netw (2010) 1.05
Formal and informal support needs of young women with BRCA mutations. J Psychosoc Oncol (2008) 1.02
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet (2000) 1.02
Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings. J Genet Couns (2009) 0.97
Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments. J Genet Couns (2007) 0.96
Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genet Med (2011) 0.95
Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry. J Psychosoc Oncol (2008) 0.95
Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. J Genet Couns (2007) 0.95
Genetic cancer risk assessment. Putting it all together. Cancer (1999) 0.92
Cancer genetic predisposition: information needs of patients irrespective of risk level. Fam Cancer (2009) 0.89
A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs (2008) 0.87
Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clin Genet (2002) 0.85
Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science. J Cancer Surviv (2009) 0.85
Beyond clinical trials and narratives: a participatory action research with cancer patient self-help groups. Patient Educ Couns (2006) 0.81
Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice. J Clin Oncol (2005) 0.81
The Unmet Information and Support Needs of Women with a Family History of Breast Cancer: A Descriptive Survey. J Genet Couns (2003) 0.79
Beginning an action research project to investigate the feasibility of a midwife-led normal birthing unit in China. J Clin Nurs (2009) 0.78
Support groups for people carrying a BRCA mutation. CMAJ (2001) 0.77
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet (2010) 9.72
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet (2010) 8.41
Breast-cancer risk in families with mutations in PALB2. N Engl J Med (2014) 4.97
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol (2009) 4.84
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA (2007) 2.91
Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genet Med (2008) 2.53
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2010) 2.45
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol (2012) 2.40
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev (2005) 2.00
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns (2011) 1.92
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin (2011) 1.90
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns (2004) 1.69
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg (2003) 1.57
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet (2010) 1.56
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer (2005) 1.48
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw (2014) 1.48
Genome-wide association studies of cancer. J Clin Oncol (2010) 1.45
Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples. Psychol Assess (2004) 1.35
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol (2012) 1.28
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev (2007) 1.25
Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Gynecol Oncol (2003) 1.23
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2011) 1.22
Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Educ Couns (2006) 1.19
RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS One (2011) 1.12
Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psychooncology (2008) 1.11
Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genet Med (2007) 1.09
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat (2012) 1.09
Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat (2011) 1.07
Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. J Natl Compr Canc Netw (2010) 1.05
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res (2011) 1.05
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Educ Couns (2011) 1.03
Clarifying the expectations of patients undergoing implant breast reconstruction: a qualitative study. Plast Reconstr Surg (2010) 1.03
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res (2009) 1.01
Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models. Mol Cancer Ther (2012) 1.00
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer (2014) 0.97
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2006) 0.97
Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings. J Genet Couns (2009) 0.97
Genetic information: Special or not? Responses from focus groups with members of a health maintenance organization. Am J Med Genet A (2007) 0.96
The Healthy Connections project: a community-based participatory research project involving women at risk for diabetes and hypertension. Prog Community Health Partnersh (2009) 0.96
Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers. J Genet Couns (2003) 0.96
The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS One (2012) 0.95
Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genet Med (2011) 0.95
Beliefs and interest in cancer risk in an underserved Latino cohort. Prev Med (2006) 0.94
Chest and upper body morbidity following immediate postmastectomy breast reconstruction. Ann Surg Oncol (2013) 0.93
Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genet Med (2005) 0.93
Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics. Breast Cancer Res Treat (2009) 0.92
Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine. JAMA (2006) 0.92
Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers. Clin Cancer Res (2007) 0.91
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. Gynecol Oncol (2011) 0.91
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol (2012) 0.91
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res (2013) 0.90
Comparison of Latina and non-Latina white women's beliefs about communicating genetic cancer risk to relatives. J Health Commun (2008) 0.90
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival. Cancer Genet (2012) 0.90
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2014) 0.89
Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations. Semin Oncol (2011) 0.88
Pathological characteristics of BRCA-associated breast cancers in Hispanics. Breast Cancer Res Treat (2011) 0.88
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet (2011) 0.87
Creating tomorrow's leaders in cancer prevention: a novel interdisciplinary career development program in cancer genetics research. J Cancer Educ (2006) 0.87
Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer (2010) 0.86
Future directions for postdoctoral training in cancer prevention: insights from a panel of experts. Cancer Epidemiol Biomarkers Prev (2014) 0.85
Evolving perspectives on genetic discrimination in health insurance among health care providers. Fam Cancer (2010) 0.85